| Literature DB >> 24799334 |
Teruhito Aihara1, Norimasa Morita2, Nobuhiko Kamitani3, Hiroaki Kumada4, Koji Ono5, Junichi Hiratsuka3, Tamotsu Harada2.
Abstract
The therapeutic effect of surgery and/or combination of conventional chemoradiotherapy is limited in the patients with recurrent squamous cell carcinoma (SCC) and locally advanced non-squamous cell carcinoma without malignant melanoma (non-SCC) of the head and neck. Currently, clinical trials of BNCT for head and neck cancers are being conducted in some institutes to verify its the effectiveness. BNCT was performed in 10 patients with recurrent SCC, 7 patients with recurrent non-SCC and 3 patients with newly diagnosed non-SCC in our university between October 2003 and September 2007. Eleven patients showed complete remission and 7 patients showed partial remission of irradiated site. The effective rate [(CR+PR)/total cases] was 90%. No severe acute or chronic normal-tissue reactions were observed in any patients. BNCT is effective and safe in the patients with recurrent SCC and locally advanced non-SCC.Entities:
Keywords: BNCT; Head and neck cancer; Locally advanced non-SCC; Recurrent SCC
Mesh:
Year: 2014 PMID: 24799334 DOI: 10.1016/j.apradiso.2014.04.007
Source DB: PubMed Journal: Appl Radiat Isot ISSN: 0969-8043 Impact factor: 1.513